RE: Eric Topol Again25 Sep 2020 00:07
Further information
Immunologist Jean-Laurent Casanova of the Rockefeller University suspects human genetics will end up explaining the majority of such serious cases, however, because the consortium has only looked for mutations in 13 of the 300-odd type 1 interferon-related genes so far – already a huge undertaking. Many other genes, including ones not related to interferon, could affect a person’s response to the virus.
So the 14% figure is likely to be very much higher. It gets to the point that the evidence could point to giving all patients a boost of IFN-B as the first stage drug.